Trademark Overview
On Friday, November 21, 2025, a trademark application was filed for IMSECMA with the United States Patent and Trademark Office. The USPTO has given the IMSECMA trademark a serial number of 79440140. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Thursday, March 5, 2026. This trademark is owned by CELLTRION, INC.. The IMSECMA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of inflammatory diseases; monoclonal antibodies for medical purposes; medicines for human purposes; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of spondylitis; pharmaceutical preparations for the treatment of hidradenitis suppurativa.